Russia completes volunteer recruitment for COVID-19 vaccine trial

Russia completes volunteer recruitment for COVID-19 vaccine trial

A photo shows an employee demonstrating vials with vaccine against the coronavirus disease (COVID-1
A photo shows an employee demonstrating vials with vaccine against the coronavirus disease (COVID-19) near Moscow

MOSCOW: Russia has recruited sufficient participants for its large-scale COVID-19 vaccine trial, known as a Phase III trial, the head of Russia's sovereign wealth fund, which is backing the vaccine, said on Monday (Sep 14).

"In just two weeks, 55,000 volunteers have already been recruited in Moscow," Kirill Dmitriev, head of the Russian Direct Investment Fund Said.

Russia began recruiting for what was billed as a 40,000-strong Phase III trial on Aug 26. Initial results are expected in October or November this year, officials have said.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Bookmark